U.S. Lidocaine Patch Industry - Regional Synopsis
Southeast Market Analysis
Southeast U.S. lidocaine patches market is expected to hold revenue share of more than 25.7% by 2037, due to growing healthcare infrastructure coupled with an increase in the population aged 65 years or more. Several states of this region are investing in facilities regarding palliative care because of the prevalence of disorders related to chronic pain. Awareness for solutions connected with the management of pain without the help of opioids is being created through various campaigns, which is further escalating the use of lidocaine patches. The Southeast U.S. lidocaine patches market is anticipated to be lucrative due to healthcare providers advocating pain relief methods in localized forms.
Midwest U.S. Lidocaine Patches Market Statistics
Midwest United States lidocaine patches market is predicted to register growth of around 5.8% till 2034. As a matter of fact, significant awareness of localized pain management solution options, along with aging populations in the region, could also propel market growth in this segment. Hisamitsu America announced the introduction of its advanced thin and flexible technology-based Salonpas Pain Relieving FLEX Patch Lidocaine 4% in June 2022. The innovation aims at the preference of consumers towards OTC solutions, providing comfort associated with effectiveness. The launch reflects the growing demand for user-friendly lidocaine patches that are designed to meet the diverse needs of consumers in the Midwest.
